Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Acute Treatment
Addictive Behaviors | Mental Health & Behavioral Research | Obesity & Weight Control
What is the purpose of this trial?
Brief Summary: This study will compare the effectiveness of cognitive behavioral therapy (CBT), lisdexamfetamine (LDX), and the combination of CBT and LDX for the treatment of binge-eating disorder in patients with obesity. This is an acute treatment comparing CBT or LDX alone or in combination.
- Ages18 years - 64 years
- Trial withNational Institute of Diabetes and Digestive & Kidney Diseases (NIDDK)
- Start Date03/22/2019
- End Date08/31/2025
- Last Updated07/15/2021
- Study HIC#2000022480